AP

Amphastar Pharmaceuticals

AMPH
NASDAQHealth Care

Income Statement

Total Revenue$731.97M
Gross Profit$373.86M
Operating Income$205.42M
EBITDA$276.74M
EBIT$219.53M
Pre-tax Income$102.81M
Net Income$159.52M

Balance Sheet

Cash Equivalent$183.86M
Total Debt$632.02M
Book Value$711.42M
Book Value Per Share14.69

Key Ratios

Return on Equity (ROE)+21.78%
Return on Assets (ROA)+10.11%
Return on Invested Capital (ROI)+11.96%
Net Profit Margin+21.79%
Current Ratio3.07
Quick Ratio2.08
Long-Term Debt / Equity0.82